Status:
COMPLETED
Supermicrosurgical LVA for Lymphedema Treatment
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Lymphedema
Eligibility:
All Genders
20-100 years
Brief Summary
LVA orientations such as lymphaticovenous end-to-end (LVEEA), end-to-side (LVESA), and side-to-end (LVSEA) are commonly performed. Each orientation has its own advantages and disadvantages. The key fa...
Eligibility Criteria
Inclusion
- lymphedematous lower limbs (International Society of Lymphology stage I-III) between March 2016 to October 2018 were included
Exclusion
- Patients whose data were missing will be excluded.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04285762
Start Date
November 1 2018
End Date
December 31 2019
Last Update
February 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301